Vyant Bio, Inc.
VYNTDelisted May 4, 2023- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001349929
Vyant Bio, Inc. was delisted on May 4, 2023; its insiders filed their last Form 4 on Feb 27, 2023; 17 institutions reported holding it in 13F filings for Q1 2023, worth $136.8K in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Vyant Bio, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −2 vs. Q1 2022
- Shares held
- 1.62M
- −197.6K (−10.9%) vs. Q1 2022
- Total value
- $1.47M
- −$1.07M (−42.0%) vs. Q1 2022
- New holders
- 2
- 6 more added
- Sold out
- 4
- 4 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VYNT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 1 | $1 |
| Q1 2023 | 17 | $136.8K |
| Q4 2022 | 17 | $222.1K |
| Q3 2022 | 26 | $949.3K |
| Q2 2022 | 21 | $1.47M |
| Q1 2022 | 23 | $2.54M |
| Q4 2021 | 27 | $3.12M |
| Q3 2021 | 23 | $5.27M |
| Q2 2021 | 29 | $8.41M |
| Q1 2021 | 18 | $2.96M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Vyant Bio, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 756,799 | $688.0K | 0.00% | 00.0% | Unchanged |
| Frontier Wealth Management LLC | 202,601 | $184.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 194,586 | $177.0K | 0.00% | +5,784+3.1% | Added |
| BlackRock Inc. | 132,797 | $121.0K | 0.00% | −77,117−36.7% | Reduced |
| State Street Corp | 75,200 | $68.0K | 0.00% | +3,200+4.4% | Added |
| Northern Trust Corp | 43,901 | $40.0K | 0.00% | 00.0% | Unchanged |
| Jackson Square Capital, LLC | 30,389 | $28.0K | 0.01% | 00.0% | Unchanged |
| US Bancorp | 24,813 | $23.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 25,611 | $23.0K | 0.00% | +25,611 | New |
| Country Club Bank | 20,000 | $18.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 20,049 | $18.0K | 0.00% | −22−0.1% | Reduced |
| Renaissance Technologies LLC | 20,300 | $18.0K | 0.00% | +890+4.6% | Added |
| NorthRock Partners, LLC | 18,832 | $17.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 17,437 | $16.0K | 0.00% | +8,148+87.7% | Added |
| AE Wealth Management LLC | 13,933 | $13.0K | 0.00% | +393+2.9% | Added |
| Carlson Capital Management | 11,800 | $11.0K | 0.00% | 00.0% | Unchanged |
| Taylor Wealth Management Partners | 10,273 | $9.00K | 0.01% | −3,424−25.0% | Reduced |
| Wells Fargo & Company | 179 | $0 | 0.00% | +17+10.5% | Added |
| Barclays PLC | 15 | $0 | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 50 | $0 | 0.00% | −74−59.7% | Reduced |
| FMR LLC | 21 | $0 | 0.00% | +21 | New |
| Cerity Partners LLC | 0 | $0 | 0.00% | −119,535−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −35,184−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −5,459−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −800−100.0% | Sold out |